Farapulse

Advanced cardiac ablation solutions for atrial fibrillation treatment

placeMenlo Park, California, United States calendar_todayFounded 2014 groups45 employees language farapulse.com

Innovation

33 patent families (24 granted) — focus: Human necessities; filing pace slowing. Cited 25,209 times.

YearFilings
20186
201919
202024
202117
202215
20239
20243

Investor mix

5 investors on record; lead investors include Boston Scientific, F-Prime Capital; 1 has since exited.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon